These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8861655

  • 1. Characterization of the genetic polymorphism of dihydrocodeine O-demethylation in man via analysis of urinary dihydrocodeine and dihydromorphine by micellar electrokinetic capillary chromatography.
    Hufschmid E, Theurillat R, Wilder-Smith CH, Thormann W.
    J Chromatogr B Biomed Appl; 1996 Mar 29; 678(1):43-51. PubMed ID: 8861655
    [Abstract] [Full Text] [Related]

  • 2. Exploration of the metabolism of dihydrocodeine via determination of its metabolites in human urine using micellar electrokinetic capillary chromatography.
    Hufschmid E, Theurillat R, Martin U, Thormann W.
    J Chromatogr B Biomed Appl; 1995 Jun 09; 668(1):159-70. PubMed ID: 7550973
    [Abstract] [Full Text] [Related]

  • 3. Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans.
    Fromm MF, Hofmann U, Griese EU, Mikus G.
    Clin Pharmacol Ther; 1995 Oct 09; 58(4):374-82. PubMed ID: 7586928
    [Abstract] [Full Text] [Related]

  • 4. The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers.
    Wilder-Smith CH, Hufschmid E, Thormann W.
    Br J Clin Pharmacol; 1998 Jun 09; 45(6):575-81. PubMed ID: 9663813
    [Abstract] [Full Text] [Related]

  • 5. Analysis of codeine, dihydrocodeine and their glucuronides in human urine by electrokinetic capillary immunoassays and capillary electrophoresis-ion trap mass spectrometry.
    Wey AB, Caslavska J, Thormann W.
    J Chromatogr A; 2000 Oct 20; 895(1-2):133-46. PubMed ID: 11105855
    [Abstract] [Full Text] [Related]

  • 6. Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis.
    Webb JA, Rostami-Hodjegan A, Abdul-Manap R, Hofmann U, Mikus G, Kamali F.
    Br J Clin Pharmacol; 2001 Jul 20; 52(1):35-43. PubMed ID: 11453888
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine.
    Kirkwood LC, Nation RL, Somogyi AA.
    Br J Clin Pharmacol; 1997 Dec 20; 44(6):549-55. PubMed ID: 9431830
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing.
    Ammon S, Hofmann U, Griese EU, Gugeler N, Mikus G.
    Br J Clin Pharmacol; 1999 Sep 20; 48(3):317-22. PubMed ID: 10510141
    [Abstract] [Full Text] [Related]

  • 9. The role of dihydrocodeine (DHC) metabolites in dihydrocodeine-related deaths.
    Al-Asmari AI, Anderson RA.
    J Anal Toxicol; 2010 Oct 20; 34(8):476-90. PubMed ID: 21819793
    [Abstract] [Full Text] [Related]

  • 10. Affinities of dihydrocodeine and its metabolites to opioid receptors.
    Schmidt H, Vormfelde Sv, Klinder K, Gundert-Remy U, Gleiter CH, Skopp G, Aderjan R, Fuhr U.
    Pharmacol Toxicol; 2002 Aug 20; 91(2):57-63. PubMed ID: 12420793
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of urinary dihydrocodeine excretion in human by gas chromatography-mass spectrometry.
    Balikova M, Maresova V, Habrdova V.
    J Chromatogr B Biomed Sci Appl; 2001 Mar 05; 752(1):179-86. PubMed ID: 11254193
    [Abstract] [Full Text] [Related]

  • 12. Formation and clearance of active and inactive metabolites of opiates in humans.
    Aderjan RE, Skopp G.
    Ther Drug Monit; 1998 Oct 05; 20(5):561-9. PubMed ID: 9780136
    [Abstract] [Full Text] [Related]

  • 13. Metabolism and pharmacokinetics of dihydrocodeine in dog.
    Konishi M, Shiono Y, Ohno M, Takahashi H, Aoki T.
    Xenobiotica; 1994 Jul 05; 24(7):591-601. PubMed ID: 7975724
    [Abstract] [Full Text] [Related]

  • 14. Dihydrocodeine: safety concerns.
    Leppert W, Woroń J.
    Expert Rev Clin Pharmacol; 2016 Jul 05; 9(1):9-12. PubMed ID: 26479786
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous determination of dihydrocodeine and dihydromorphine in serum by gas chromatography-tandem mass spectrometry.
    Hofmann U, Fromm MF, Johnson S, Mikus G.
    J Chromatogr B Biomed Appl; 1995 Jan 06; 663(1):59-65. PubMed ID: 7704214
    [Abstract] [Full Text] [Related]

  • 16. Analgesia and serum assays of controlled-release dihydrocodeine and metabolites in cancer patients with pain.
    Leppert W, Mikołajczak P, Kamińska E, Szulc M.
    Pharmacol Rep; 2012 Jan 06; 64(1):84-93. PubMed ID: 22580524
    [Abstract] [Full Text] [Related]

  • 17. Analgesia by dihydrocodeine is not due to formation of dihydromorphine: evidence from nociceptive activity in rat thalamus.
    Jurna I, Kömen W, Baldauf J, Fleischer W.
    J Pharmacol Exp Ther; 1997 Jun 06; 281(3):1164-70. PubMed ID: 9190849
    [Abstract] [Full Text] [Related]

  • 18. The role of active metabolites in dihydrocodeine effects.
    Schmidt H, Vormfelde SV, Walchner-Bonjean M, Klinder K, Freudenthaler S, Gleiter CH, Gundert-Remy U, Skopp G, Aderjan R, Fuhr U.
    Int J Clin Pharmacol Ther; 2003 Mar 06; 41(3):95-106. PubMed ID: 12665158
    [Abstract] [Full Text] [Related]

  • 19. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.
    Yue QY, Svensson JO, Alm C, Sjöqvist F, Säwe J.
    Br J Clin Pharmacol; 1989 Dec 06; 28(6):639-45. PubMed ID: 2611086
    [Abstract] [Full Text] [Related]

  • 20. Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.
    Mortimer O, Persson K, Ladona MG, Spalding D, Zanger UM, Meyer UA, Rane A.
    Clin Pharmacol Ther; 1990 Jan 06; 47(1):27-35. PubMed ID: 2295216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.